These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 483575)

  • 21. Interferon action: two (2'-5')(A)n synthetases specified by distinct mRNAs in Ehrlich ascites tumor cells treated with interferon.
    St Laurent G; Yoshie O; Floyd-Smith G; Samanta H; Sehgal PB; Lengyel P
    Cell; 1983 May; 33(1):95-102. PubMed ID: 6205763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A protein synthesizing system from interferon-treated cells that discriminates between cellular and viral messenger RNAs.
    Samuel CE; Joklik WK
    Virology; 1974 Apr; 58(2):476-91. PubMed ID: 4820887
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of protein synthesis and activation of nuclease in rabbit reticulocyte lysates by the unusual oligonucleotide pppA2'p5'A2'p5'A.
    Vaquero CM; Clemens MJ
    Eur J Biochem; 1979 Jul; 98(1):245-52. PubMed ID: 467443
    [No Abstract]   [Full Text] [Related]  

  • 24. Mechanism of interferon action: inhibition of pppA(2'p5'A)n-dependent ribonucleases activity in micrococcal nuclease-treated mouse L cell-free extracts.
    Miyamoto NG; Samuel CE
    Biochem Biophys Res Commun; 1981 Jul; 101(2):680-8. PubMed ID: 6171274
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-regulatory functions of interferon induced enzymes: antimitogenic effect of (2'-5')oligo-A, growth-related variations in (2'-5')oligo-A synthetase, and isolation of its mRNA.
    Revel M; Kimchi A; Friedman M; Wolf D; Merlin G; Panet A; Rapoport S; Lapidot Y
    Tex Rep Biol Med; 1981-1982; 41():452-62. PubMed ID: 6189209
    [No Abstract]   [Full Text] [Related]  

  • 26. Increased nuclease activity in cells treated with pppA2'p5'A2'p5' A.
    Hovanessian AG; Wood J; Meurs E; Montagnier L
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3261-5. PubMed ID: 114998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure--activity relationships for and potentiation of the antimitogenic activity of 2-5A core derived from 2-5A, a mediator of interferon action.
    Torrence PF; Imai J; Lesiak K; Warrinnier J; Balzarini J; De Clercq E
    J Med Chem; 1983 Dec; 26(12):1674-8. PubMed ID: 6196481
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.
    Clemens MJ; Williams BR
    Cell; 1978 Mar; 13(3):565-72. PubMed ID: 657268
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular mechanisms of interferon action: interferon-mediated phosphorylation of ribosome-associated protein P1 and protein synthesis initiation factor eIF-2.
    Samuel CE
    Tex Rep Biol Med; 1981-1982; 41():463-70. PubMed ID: 6189210
    [No Abstract]   [Full Text] [Related]  

  • 30. Interferon-induced enzymatic activities and their role in the antriviral state.
    Baglioni C
    Cell; 1979 Jun; 17(2):255-64. PubMed ID: 455463
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon-induced enzymes: activation and role in te antiviral state.
    Baglioni C; Benvin S; Maroney PA; Minks MA; Nilsen TW; West DK
    Ann N Y Acad Sci; 1980; 350():497-509. PubMed ID: 6165300
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of preincubation on the development of the inhibition of protein synthesis in extracts from interferon-treated mouse L cells. Action on tRNA.
    Falcoff R; Falcoff E; Sanceau J; Lewis JA
    Virology; 1978 May; 86(2):507-15. PubMed ID: 208258
    [No Abstract]   [Full Text] [Related]  

  • 33. Procedures for the assay of (2'-5')-oligoadenylic acids and their derivatives in intact cells.
    Martin EM; Reisinger DM; Hovanessian AG; Williams BR
    Methods Enzymol; 1981; 79(Pt B):273-84. PubMed ID: 6173673
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiproliferative effect of (2'-5') oligoadenylate distinct from that of interferon in lymphoid cells.
    Leanderson T; Nordfelth R; Lundgren E
    Biochem Biophys Res Commun; 1982 Jul; 107(2):511-7. PubMed ID: 6181787
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of features in 5' terminal fragments from reovirus mRNA which are important for ribosome binding.
    Kozak M; Shatkin AJ
    Cell; 1978 Jan; 13(1):201-12. PubMed ID: 620422
    [No Abstract]   [Full Text] [Related]  

  • 36. Ribosomal RNA cleavage, nuclease activation and 2-5A(ppp(A2'p)nA) in interferon-treated cells.
    Wreschner DH; James TC; Silverman RH; Kerr IM
    Nucleic Acids Res; 1981 Apr; 9(7):1571-81. PubMed ID: 6164990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of interferon action. Partial purification and characterization of a low-molecular-weight interferon-mediated inhibitor of translation with nucleolytic activity.
    Eppstein DA; Samuel CE
    Biochem Biophys Res Commun; 1977 Nov; 79(1):145-53. PubMed ID: 921792
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferon, double-stranded RNA and RNA degradation. Characteristics of an endonuclease activity.
    Ratner L; Sen GC; Brown GE; Lebleu B; Kawakita M; Cabrer B; Slattery E; Lengyel P
    Eur J Biochem; 1977 Oct; 79(2):565-77. PubMed ID: 923567
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of reovirus messenger RNA methylation in extracts of interferon-treated Ehrlich ascites tumor cells.
    Sen GC; Lebleu B; Brown GE; Rebello MA; Furuichi Y; Morgan M; Shatkin AJ; Lengyel P
    Biochem Biophys Res Commun; 1975 Jul; 65(1):427-34. PubMed ID: 1147999
    [No Abstract]   [Full Text] [Related]  

  • 40. The 2-5A (pppA2'p5'A2'p5'A) and protein kinase systems in interferon-treated and control cells.
    Kerr IM; Wreschner DH; Silverman RH; Cayley PJ; Knight M
    Adv Cyclic Nucleotide Res; 1981; 14():469-78. PubMed ID: 6169260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.